Le Lézard
Classified in: Health
Subjects: CHI, SVY, AVO

Several In Utero Fluoride/IQ Studies Should Provoke A Nation-Wide Fluoridation Moratorium


NEW YORK, Aug. 30, 2019 /PRNewswire/ -- Critics of the fluoride-IQ study published this month in JAMA Pediatrics claimed it needed replication. However, the Canadian study by Green (2019) was already a replication of another U.S. government-funded study published in 2017 by Bashash which found similar effects, reports the Fluoride Action Network (FAN).

Both were Mother-Offspring studies that used urinary fluoride levels during pregnancy to assess cognition in the paired offspring. 

Both studies have shown a strong relationship between maternal exposure to fluoride and lowered IQ in offspring. Each revealed that the fetal stage appears to be the most vulnerable time period for fluoride's neurotoxicity.

Actually, FAN points out that there have been five studies that have found this relationship between maternal exposure and lowered IQ in children (see listing below). However, the Canadian study is the first to compare fluoridated vs non-fluoridated cities. The pregnant women in Canada with higher urinary fluoride levels had offspring with lower IQs and were from the fluoridated cities.

Paul Connett, PhD, FAN Executive Director, says, "For years promoters of fluoridation have argued that there is no harm from fluoridation; these and other studies indicate that there is potential harm and it is serious. It is unconscionable to continue fluoridation until this is resolved. For those who doubt the current findings more studies can be done once a moratorium on fluoridation is in place. To do otherwise is to condone a human experiment on millions of children."

Connett adds, "To ignore brain health and continue fluoridation in name of dental health is a huge disservice to the children of this country. FAN argues that there are more effective programs to reduce dental inequities (eg, 'Childsmile' in Scotland) and communities can easily implement them."

The Mother-Offspring studies, listed below, can be accessed at http://fluoridealert.org/issues/moms2b/mother-offspring-studies/

Green (2019). Largest study with 512 mother-offspring. Lower IQ in children 3- 4 years of age.

Bashash (2017). Longest study. 299 mother-offspring pairs in Mexico. Lower IQ in children 4 and 6-12 years of age.

Thomas (2018). 401 mother-offspring pairs in Mexico. Lower IQ in children 1-3 years of age Only the abstract has been published.

Valdez Jiménez (2017). Lower IQ between the ages of 3-15 months with 65 mother-offspring pairs in Mexico.

Li (2004). Significant differences in the neonatal behavioral neurological assessment score in 91 offspring aged 1-3 days old.

SOURCE Fluoride Action Network


These press releases may also interest you

at 21:05
Unlearn.AI, developer of the first machine-learning (ML) platform that creates Digital Twins to populate Intelligent Control Arms in clinical studies, today presented results generated from the company's latest Alzheimer's disease model at the...

at 20:00
The 12-Step fellowship, Nicotine Anonymous (NicA), has grown in 37 years to have over 700 weekly ongoing face-to-face mutual support groups in 32 countries. At meetings members share their experience with a process of recovery from nicotine...

at 17:35
MaaT Pharma announced today that leading hemato-oncological experts presented clinical data on the compassionate use of MaaT Pharma's lead full-ecosystem microbiome restoration biotherapeutic, MaaT013. The data included eight patients that developed...

at 17:35
Magenta Therapeutics , a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that new results from its MGTA-145 stem cell mobilization program were presented at...

at 16:05
The Bristol-Myers Squibb-Pfizer Alliance today announced results from retrospective real-world data analyses reporting outcomes on the safety and effectiveness of Eliquis® (apixaban) compared to low molecular weight heparin (LMWH) or warfarin for the...

at 14:30
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Baxter International Inc. between February 21, 2019 and October 23, 2019, inclusive (the "Class Period") of the important January 24, 2020 lead plaintiff...



News published on 30 august 2019 at 09:32 and distributed by: